This page is part of the Pharmaceutical Quality (Industry) (v1.0.0: STU1) based on FHIR (HL7® FHIR® Standard) v5.0.0. This is the current published version in its permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions
Details about compatibility studies and results.
MedicinalProductDefinition | The drug product (Stelbat tablets, 20mg) |
Medication | Describes the batches that underwent testing |
Ingredient | The active ingredient (stelbatalol) or the ingredients that make up the drug product |
SubstanceDefinition | Chemical or biological details about substance(s) associated with the ingredient |
PlanDefinition | Describes the compatibility analysis protocol |
ObservationDefinition | Each individual test and acceptance criteria; also used to group tests |
Observation | The results of a specific test mentioned in the ObservationDefinition |
DiagnosticReport | Contains all results as a group and captures conclusions |
CTD section samples (PDF):
XML and JSON examples of synthetic quality data:
HTML rendering of synthetic quality data: